LPTX
Leap Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.77
−3.15%Leverage
- Debt / equity
- 0.00x
- Net debt / equity
- -0.09x
- Debt / assets
- 0.00x
- Debt / EBITDA
- -0.00x
- Net debt / EBITDA
- 0.35x
Liquidity & coverage
- Current ratio
- 35.56x
- Quick ratio
- 35.56x
- Cash ratio
- 3.08x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $157.5M
Cash & dividend
- FCF / debt
- -2386.74x
- Cash flow / debt
- -2334.32x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Dec 1, 2025